Cytokines have long been considered promising cancer immunotherapy agents due to their
endogenous role in activating and proliferating lymphocytes. However, since the initial FDA …

Cytokines bind to specific receptors on target cells to activate intracellular signaling
pathways that control diverse cellular functions, such as proliferation, differentiation …

Cancer immunotherapy targets immune cells to trigger a highly specific, long-lasting anti-
tumor response. With the clinical success of immune checkpoint blockade and the …